| September 24, 2003 |
Kyowa Hakko Produces Tablet Version |
|
Kyowa Hakko Kogyo Co., Ltd., one of Japan’s leading developers of pharmaceutical and biotechnology products, has produced a tablet version of CSPHP®*, its novel cholesterol-lowering food ingredient. This development will allow dietary supplement makers to make CSPHP-based cholesterol-lowering tablets or capsules for consumers to incorporate into their daily diet, and follows the successful launch of a liquid version of CSPHP in July 2003. Kyowa Hakko will be showcasing the active ingredient, CSPHP, along with tablets and the data from its latest trials at the Supply Side West show in Las Vegas from October 1-3, 2003. Kyowa will also demonstrate its in-house capsuling and bottling capabilities in the USA, which enable supplement companies to quickly launch new products to the market, and will outline the consulting service it offers to help manufacturers devise effective advertising that meets regulatory requirements. A randomized, double blind placebo controlled trial of 75 subjects, reported in the Japanese Pharmacology & Therapeutics journal (vol.31, no. 7), concluded that 3 grams per day of CSPHP in tablet form over 4 weeks or beyond had a significant effect in reducing serum cholesterol levels in mildly hypercholesterolemic subjects (serum total cholesterol: 220 - 240mg/dl). At the same time, 1.5g seemed to possess potential to lower cholesterol in a dose responsive manner. "CSPHP is an increasingly popular and important cholesterol lowering agent in the growing Japanese functional food market, and we are excited to be adding the tablet version to the powder and liquid formats already being widely adopted in the industry," said Tadayasu Furukawa, President of Kyowa Hakko’s Food Company. "We expect that its proven efficacy in lowering cholesterol will appeal to millions of health-conscious consumers looking for effective dietary supplements." According to the National Heart, Lung, and Blood Institute's National Cholesterol Education Program, about 50 percent of American adults have elevated blood cholesterol levels - one of the key risk factors for heart disease, the number one killer of both men and women in the U.S. Cognizin®, a branded citicholine ingredient for brain health, and amino acids will also be showcased.
As a food additive CSPHP is highly stable, retaining its properties even through high temperature food manufacturing processes. Because CSPHP can be added to proteins, lipids, starches, and minerals it can be used as an active health ingredient in a wide range of consumer-acceptable foods, drinks, and dietary supplements. Japan’s Ministry of Health, Labor, and Welfare officially recognizes CSPHP as a ’Food for Specified Health Use (FOSHU).’ For the U.S. market, CSPHP has been self-affirmed GRAS (Generally Recognized As Safe) through an independent evaluation by an expert panel.
URL: http://www.kyowa.co.jp/eng/
|
